what is tirzepatide called — IVs in the Keys Tirzepatide Peptide: How It Works
Description
Tirzepatide patients lose more weight on average (about 15-20% vs

Specifically, 27 of 542 participants (5.0%) in the older subgroup without obesity reported decreased weight as a TEAE, with five discontinuing study medication due to this adverse event
Tirzepatide is not approved for use in type 1 diabetes or for the treatment of diabetic ketoacidosis
The total daily dose for adults should not exceed 0.5 mg/kg/day

Journal of Clinical Endocrinology & Metabolism, 109(4), 845856

Tirzepatide side effects are very uncommon
